Interpace Biosciences (OTC: IDXG)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Interpace Biosciences (OTCQX: IDXG) through any online brokerage.
There are no as such competitors for Interpace Biosciences.
The latest price target for Interpace Biosciences (OTCQX: IDXG) was reported by HC Wainwright & Co. on Wednesday, November 17, 2021. The analyst firm set a price target for 0.00 expecting IDXG to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Interpace Biosciences (OTCQX: IDXG) is $3.2 last updated July 1, 2022, 6:51 PM UTC.
There are no upcoming dividends for Interpace Biosciences.
Interpace Biosciences’s Q3 earnings are confirmed for Wednesday, November 10, 2021.
There is no upcoming split for Interpace Biosciences.
Interpace Biosciences is in the Health Care sector and Health Care Providers & Services industry. They are listed on the OTCQX.